MBIO

0.6054 -0.41%
Mustang Bio, Inc. NASDAQ Stock Pharmaceutical Stocks
Open in Risen →

Mustang Bio, Inc. (MBIO) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time MBIO price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.

Technical Analysis

RSI (14) 44.8 Neutral
Market Cap $4.1M
Volume 9.9K

Fundamentals — 10-Q Q2 2026

Revenue --
Net Income $-2.0M
EPS $-0.30
P/E Ratio -2.0x

Earnings

Recent Insider Trades

Name Title Type Shares Price Value Date
Chill Adam J. Director Sell 4 $0.95 $4 2025 Dec 30
Jin David Director Buy 247 $0.96 $237 2025 Dec 30
Herskowitz Neil Director Sell 247 $0.96 $237 2025 Dec 30
Litchman Manuel MD Director Buy 10,000 $0.63 $6,300 2022 Sep 13
Rosenwald Lindsay A Md Director Buy 9,094 $0.62 $5,630 2022 Sep 13
Achenbach Brian SVP, Fin. & Corp. Controller Sell 4,374 $1.83 $8,004 2021 Dec 14
Litchman Manuel MD President and CEO Buy 65,000 $2.24 $145,600 2021 Oct 27
Achenbach Brian SVP, Fin. & Corp. Controller Sell 4,450 $2.28 $10,146 2021 Oct 12
Litchman Manuel MD President and CEO Buy 86,206 $2.91 $250,859 2021 Jul 30
Achenbach Brian SVP, Fin. & Corp. Controller Sell 20,721 $3.20 $66,282 2021 Apr 9
Litchman Manuel MD President and CEO Buy 165,562 $3.12 $516,553 2021 Mar 5
Litchman Manuel MD President and CEO Buy 100,000 $2.91 $291,000 2020 Dec 15
Rosenwald Lindsay A Md Director Buy 100,000 $2.66 $266,000 2020 Dec 14
Litchman Manuel MD President and CEO Buy 153,846 $3.25 $500,000 2020 Jun 11
Litchman Manuel MD President and CEO Sell 12,373 $3.04 $37,614 2020 May 22
Litchman Manuel MD President and CEO Buy 180,000 $2.96 $532,800 2020 May 21
Litchman Manuel MD President and CEO Buy 28,000 $3.71 $103,925 2018 Dec 10
Herskowitz Neil Director Buy 1,000 $3.96 $3,960 2018 Nov 23
Achenbach Brian VP, Fin. & Corp. Controller Buy 2,500 $4.20 $10,495 2018 Nov 20
Rosenwald Lindsay A Md Director Buy 50,000 $4.41 $220,500 2018 Nov 2

Take MBIO further

Set alerts on MBIO

Get notified when Mustang Bio, Inc. hits your price targets or technical conditions are met.

Get Started Free